Literature DB >> 8596931

Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase.

D Grieco1, A Porcellini, E V Avvedimento, M E Gottesman.   

Abstract

Cell cycle progression in cycling Xenopus egg extracts is accompanied by fluctuations in the concentration of adenosine 3',5'-monophosphate (cAMP) and in the activity of the cAMP-dependent protein kinase (PKA). The concentration of cAMP and the activity of PKA decrease at the onset of mitosis and increase at the transition between mitosis and interphase. Blocking the activation of PKA at metaphase prevented the transition into interphase; the activity of M phase-promoting factor (MPF; the cyclin B-p34cdc2 complex) remained high, and mitotic cyclins were not degraded. The arrest in mitosis was reversed by the reactivation of PKA. The inhibition of protein synthesis prevented the accumulation of cyclin and the oscillations of MPF, PKA, and cAMP. Addition of recombinant nondegradable cyclin B activated p34cdc2 and PKA and induced the degradation of full-length cyclin B. Addition of cyclin A activated p34cdc2 but not PKA, nor did it induce the degradation of full-length cyclin B. These findings suggest that cyclin degradation and exit from mitosis require MPF-dependent activation of the cAMP-PKA pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596931     DOI: 10.1126/science.271.5256.1718

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  37 in total

1.  Mitotic regulation of the APC activator proteins CDC20 and CDH1.

Authors:  E R Kramer; N Scheuringer; A V Podtelejnikov; M Mann; J M Peters
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Protein kinase A regulatory subunits in colon cancer.

Authors:  C C Carlson; S L Smithers; K A Yeh; L L Burnham; D T Dransfield
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

3.  Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.

Authors:  N Larsson; U Marklund; H M Gradin; G Brattsand; M Gullberg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 4.  Modulation of cell cycle control during oocyte-to-embryo transitions.

Authors:  Eva Hörmanseder; Thomas Tischer; Thomas U Mayer
Journal:  EMBO J       Date:  2013-07-26       Impact factor: 11.598

5.  Kinase conformations: a computational study of the effect of ligand binding.

Authors:  V Helms; J A McCammon
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

6.  G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.

Authors:  Brian C Duckworth; Jennifer S Weaver; Joan V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

7.  Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.

Authors:  Daniel G Cordek; Tayler J Croom-Perez; Jungwook Hwang; Michele R S Hargittai; Chennareddy V Subba-Reddy; Qingxia Han; Maria Fernanda Lodeiro; Gang Ning; Thomas S McCrory; Jamie J Arnold; Hasan Koc; Brett D Lindenbach; Scott A Showalter; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-07-16       Impact factor: 5.157

8.  Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.

Authors:  James R A Hutchins; Dina Dikovskaya; Paul R Clarke
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

9.  The spindle checkpoint requires cyclin-dependent kinase activity.

Authors:  Vincenzo D'Angiolella; Cecilia Mari; Donatella Nocera; Linda Rametti; Domenico Grieco
Journal:  Genes Dev       Date:  2003-10-15       Impact factor: 11.361

10.  Protein kinase D isozymes activation and localization during mitosis.

Authors:  Romeo Papazyan; Michael Doche; Richard T Waldron; Enrique Rozengurt; Mary Pat Moyer; Osvaldo Rey
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.